The Blockbuster Drug: Are too many profiting to stop a bad drug?

The Blockbuster Drug may be just the prescription for the reader looking for a smart suspenseful novel set against the background of some of todays cutting-edge medical and legal issues. Set largely inside a major health plan located in Cincinnati this novel explores the dependent but sometimes treacherous relationships among health plans drug companies physicians and patients. Spencer Doss M.D. the health plans new Regional Medical Director stumbles onto what he believes are too many cases of a rare cancer in older patients taking the latest blockbuster drug. For help he turns to Eileen Wang the health plans in-house counsel. Wang has other issues on her plate - a cyber intrusion and an insider-trading investigation - but finds herself wondering why so many seniors are taking the expensive new drug. Maya Naidu the programmer whose data mining unearthed the excess cases of the cancer in patients taking the drug returns home to Hyderabad to be at her mothers death bed. In Shanghai the police are investigating a bribery scheme involving the drugs manufacturer. Hired to represent one of the drugs victims hotshot young attorney Ryan Ponzer doesnt have the resources to litigate with a giant drug company. Should he sue the health plan for failure to warn the health plans members of the blockbusters deadly side effects?